These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17275657)

  • 1. Safety of rapid intravenous valproate infusion in pediatric patients.
    Morton LD; O'Hara KA; Coots BP; Pellock JM
    Pediatr Neurol; 2007 Feb; 36(2):81-3. PubMed ID: 17275657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intravenous valproate.
    Devinsky O; Leppik I; Willmore LJ; Pellock JM; Dean C; Gates J; Ramsay RE
    Ann Neurol; 1995 Oct; 38(4):670-4. PubMed ID: 7574466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of rapid intravenous loading of valproate.
    Limdi NA; Knowlton RK; Cofield SS; Ver Hoef LW; Paige AL; Dutta S; Faught E
    Epilepsia; 2007 Mar; 48(3):478-83. PubMed ID: 17319914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous valproate for seizures in 137 Taiwanese children - valproate naive and non-naive.
    Chang YC; Lin JJ; Wang HS; Chou ML; Hung PC; Hsieh MY
    Acta Neurol Taiwan; 2010 Jun; 19(2):100-6. PubMed ID: 20714959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial.
    Mehta V; Singhi P; Singhi S
    J Child Neurol; 2007 Oct; 22(10):1191-7. PubMed ID: 17940245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children.
    Visudtibhan A; Bhudhisawadi K; Vaewpanich J; Chulavatnatol S; Kaojareon S
    Brain Dev; 2011 Mar; 33(3):189-94. PubMed ID: 20444563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable valproate sodium-associated hypotension.
    Ota KS
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):281-4. PubMed ID: 20624617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy.
    Wheless JW; Vazquez BR; Kanner AM; Ramsay RE; Morton L; Pellock JM
    Neurology; 2004 Oct; 63(8):1507-8. PubMed ID: 15505177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy.
    Lyczkowski DA; Pfeifer HH; Ghosh S; Thiele EA
    Epilepsia; 2005 Sep; 46(9):1533-8. PubMed ID: 16146450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy.
    Steinborn B; Galas-Zgorzalewicz B
    Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures.
    Yu KT; Mills S; Thompson N; Cunanan C
    Epilepsia; 2003 May; 44(5):724-6. PubMed ID: 12752474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients.
    Taylor LM; Farzam F; Cook AM; Lewis DA; Baumann RJ; Kuhn RJ
    Pharmacotherapy; 2007 Apr; 27(4):519-25. PubMed ID: 17381378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ; Lin KL; Wang HS; Wang CJ
    Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
    Dutta S; Faught E; Limdi NA
    J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.